APA (7th ed.) Citation

Prabhash, K., Pawar, R., & Gunjal, V. Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer. American Society of Clinical Oncology.

Chicago Style (17th ed.) Citation

Prabhash, Kumar, Roshan Pawar, and Vijaya Gunjal. Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer. American Society of Clinical Oncology.

MLA (9th ed.) Citation

Prabhash, Kumar, et al. Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer. American Society of Clinical Oncology.